WHITE PAPER
Assessment of Access-to-Medicine Timelines in Selected Countries in Middle East and Africa
Oct 13, 2022

The Middle East and Africa (MEA) region's pharma market and market access landscape continue to remain dynamic and rapidly evolving. The countries in the MEA region have different market sizes, growing complexity in securing market access, and different approaches envisaged for regulating healthcare markets. Healthcare systems and practices differ across countries, leading to different levels of access-to-medicine, primarily attributable to underlying processes, such as marketing approval and reimbursement of medicines. Read more about the current landscape of market access timelines in selected countries in the MEA region in our latest whitepaper.

Contact Us